2018 and Beyond: Netherlands Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Netherlands witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Netherlands and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Netherlands healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Netherlands healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Netherlands pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Netherlands and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Netherlands healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Netherlands healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Netherlands pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Netherlands Pharmaceutical and Healthcare Industry Snapshot
2.2 Netherlands Pharmaceuticals Market Overview
3 NETHERLANDS PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Netherlands
3.2 Drivers and Restraints
3.2.1 Market Drivers in Netherlands Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Netherlands Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 NETHERLANDS PHARMACEUTICAL MARKET OUTLOOK
4.1 Netherlands Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Netherlands Pharmaceutical Exports, $ million, 2015- 2025
4.3 Netherlands Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Netherlands (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Netherlands (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Netherlands Prescription Drug Sales, $ Million, 2015- 2025
4.7 Netherlands Generic Drug Sales, $ Million, 2015- 2025
5 NETHERLANDS HEALTHCARE MARKET OUTLOOK
5.1 Netherlands Healthcare Expenditure Outlook, 2015- 2025
5.2 Netherlands Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Netherlands Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Netherlands Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Netherlands, 2015- 2025
6 NETHERLANDS HEALTHCARE MARKET STATISTICS
6.1 Netherlands Mortality by Disease Category, 2017
6.2 Number of Hospitals in Netherlands, 2007- 2017
6.3 Number of Hospital Beds in Netherlands, 2007- 2017
6.4 Physicians Count in Netherlands, 2007- 2017
6.5 Pharmacists Count in Netherlands, 2007- 2017
7 NETHERLANDS CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Netherlands, 2017
7.2 Ongoing Clinical Trials by Disease Category in Netherlands, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 NETHERLANDS DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Netherlands Population Forecast by Age Group, 2005- 2025
8.2 Netherlands Population Forecast by Location, 2005- 2025
8.3 Netherlands GDP Forecast, 2005- 2025
8.4 Netherlands GDP Per Capita Forecast, 2005- 2025
8.5 Netherlands Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN NETHERLANDS PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Netherlands Pharmaceutical and Healthcare Industry Snapshot
2.2 Netherlands Pharmaceuticals Market Overview
3 NETHERLANDS PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Netherlands
3.2 Drivers and Restraints
3.2.1 Market Drivers in Netherlands Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Netherlands Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 NETHERLANDS PHARMACEUTICAL MARKET OUTLOOK
4.1 Netherlands Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Netherlands Pharmaceutical Exports, $ million, 2015- 2025
4.3 Netherlands Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Netherlands (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Netherlands (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Netherlands Prescription Drug Sales, $ Million, 2015- 2025
4.7 Netherlands Generic Drug Sales, $ Million, 2015- 2025
5 NETHERLANDS HEALTHCARE MARKET OUTLOOK
5.1 Netherlands Healthcare Expenditure Outlook, 2015- 2025
5.2 Netherlands Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Netherlands Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Netherlands Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Netherlands, 2015- 2025
6 NETHERLANDS HEALTHCARE MARKET STATISTICS
6.1 Netherlands Mortality by Disease Category, 2017
6.2 Number of Hospitals in Netherlands, 2007- 2017
6.3 Number of Hospital Beds in Netherlands, 2007- 2017
6.4 Physicians Count in Netherlands, 2007- 2017
6.5 Pharmacists Count in Netherlands, 2007- 2017
7 NETHERLANDS CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Netherlands, 2017
7.2 Ongoing Clinical Trials by Disease Category in Netherlands, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 NETHERLANDS DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Netherlands Population Forecast by Age Group, 2005- 2025
8.2 Netherlands Population Forecast by Location, 2005- 2025
8.3 Netherlands GDP Forecast, 2005- 2025
8.4 Netherlands GDP Per Capita Forecast, 2005- 2025
8.5 Netherlands Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN NETHERLANDS PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
